Our Pricing

Buy Mounjaro and Wegovy at the UK's Lowest Prices

Published on: June 03, 2026

When you buy Mounjaro Wegovy UK lowest price treatments at Cured Pharmacy, you're accessing genuine UK-licensed weight loss injections from £79.00, with transparent upfront pricing and free clinical consultations completed in under three minutes. Our UK-registered prescribers assess every patient individually, ensuring you receive the most appropriate GLP-1 treatment for your weight management goals.

Understanding Mounjaro and Wegovy: How These Weight Loss Injections Work

Mounjaro (tirzepatide) and Wegovy (semaglutide) represent the latest generation of weight management medications licensed by the MHRA for UK use. Both work by mimicking natural gut hormones that regulate appetite and blood sugar, but they operate through different mechanisms that produce distinct clinical outcomes [1].

Tirzepatide is the UK's first dual GIP/GLP-1 receptor agonist, activating two separate hormonal pathways simultaneously. This dual action triggers more pronounced appetite suppression and metabolic changes compared to single-pathway treatments. In the SURMOUNT-1 trial, patients taking the 15mg tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks — the highest reduction seen in any obesity medication trial to date [1].

Wegovy contains semaglutide, a selective GLP-1 receptor agonist that has demonstrated consistent efficacy across multiple clinical trials. The STEP programme showed patients on 2.4mg weekly semaglutide lost an average of 14.9% body weight over 68 weeks, with 86% of participants losing at least 5% of their starting weight [2]. Both medications require once-weekly subcutaneous injection and are prescribed alongside a reduced-calorie diet and increased physical activity.

Mounjaro vs Wegovy: Clinical Efficacy and Patient Outcomes

Direct comparison trials between tirzepatide and semaglutide have consistently shown tirzepatide producing greater average weight loss, though both medications demonstrate substantial clinical benefit when prescribed appropriately. The difference in mechanism — dual GIP/GLP-1 activation versus GLP-1 alone — appears to translate into measurable outcome differences across patient populations [3].

In head-to-head studies, patients taking tirzepatide 15mg achieved approximately 7-8 percentage points greater weight reduction compared to those on semaglutide 1mg (the dose used for diabetes management). When comparing the highest licensed doses of each medication for obesity treatment, tirzepatide maintains a statistical advantage, though individual patient response varies considerably based on metabolic factors, adherence, and lifestyle modifications [3].

Side effect profiles are similar between both medications, with gastrointestinal symptoms (nausea, diarrhoea, constipation) being most common during dose escalation. Clinical data suggests these effects are generally mild to moderate and diminish over time as patients adapt to treatment. Your UK prescriber will determine which medication suits your medical history, tolerance profile, and weight management objectives.

Which Treatment Is Right for Your Weight Loss Journey?

Choosing between Mounjaro and Wegovy depends on multiple clinical factors beyond efficacy data alone. Patients with more ambitious weight loss targets or those who haven't responded adequately to previous GLP-1 treatments may be better candidates for tirzepatide's dual-action mechanism. Conversely, patients seeking proven efficacy at a lower starting price point often find semaglutide meets their clinical needs effectively.

Your online consultation with a UK prescriber at Cured Pharmacy will assess your BMI, weight loss goals, previous treatment history, contraindications, and concurrent medications. Both treatments require gradual dose escalation over several weeks to minimise gastrointestinal side effects, and your prescriber will provide detailed guidance on injection technique, storage requirements, and what to expect during the first month of treatment.

Transparent Pricing: What You'll Actually Pay for Weight Loss Injections

At Cured Pharmacy, Mounjaro treatment starts from £79.00 per prescription, with the exact cost determined by your prescribed dose strength following clinical assessment. We display all pricing upfront before you complete your consultation — no hidden fees, no surprise charges after prescriber approval.

Unlike many UK online pharmacies that advertise low headline prices but charge significantly more for higher-dose pens, we maintain competitive pricing across all dose strengths. Our transparent model means you see the complete cost before committing to consultation, allowing you to budget accurately for ongoing treatment. All prices include the clinical consultation fee, prescriber review, and discreet home delivery.

Weight loss injection treatments typically require ongoing monthly prescriptions to maintain results, so understanding the true long-term cost is essential for treatment planning. Our superintendent pharmacist Tarun Kumar ensures every patient receives clear pricing information and realistic expectations about treatment duration before their first prescription is issued.

How to Access the Lowest UK Prices on Mounjaro and Wegovy

Accessing prescription weight loss treatments at Cured Pharmacy begins with our free online consultation, which takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any previous experience with GLP-1 treatments. A UK-registered prescriber reviews your consultation within hours and determines whether Mounjaro, Wegovy, or an alternative treatment is clinically appropriate.

Once approved, your prescription is dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched in discreet packaging with tracked delivery. We source all medications directly from UK-licensed wholesalers, guaranteeing authenticity and proper storage throughout the supply chain. Every pen comes with full patient information leaflets and injection guidance to ensure safe, effective self-administration.

Alternative Weight Loss Treatments Available at Cured Pharmacy

Not every patient requires or is suitable for the newest GLP-1 receptor agonists. Cured Pharmacy offers a comprehensive range of MHRA-licensed weight management medications to suit different clinical profiles, budgets, and treatment preferences. Saxenda (liraglutide) provides daily injection therapy for patients who prefer more frequent dosing or have specific contraindications to weekly treatments.

For patients seeking non-injectable options, we dispense prescription-strength Orlistat (120mg) and over-the-counter alternatives like Alli and Orlos. These lipase inhibitors work by blocking approximately 25-30% of dietary fat absorption, producing modest but clinically meaningful weight loss when combined with a reduced-fat diet [4]. Mysimba tablets offer another oral alternative, combining naltrexone and bupropion to target appetite regulation through different neurological pathways.

Your prescriber will discuss all suitable options during consultation, considering factors like injection tolerance, previous medication responses, concurrent health conditions, and personal preference. Many patients begin with oral medications before progressing to injectable treatments, whilst others achieve their goals with less intensive interventions when paired with structured lifestyle modifications.

Safety Considerations and Contraindications for GLP-1 Weight Loss Injections

Both Mounjaro and Wegovy carry important safety considerations that your UK prescriber will assess during consultation. These medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients with severe gastrointestinal disease, including inflammatory bowel disease or diabetic gastroparesis, may not be suitable candidates [5].

Common side effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly during the initial dose escalation phase. These symptoms typically resolve within 4-8 weeks as your body adapts to treatment. More serious but rare adverse effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). Your prescriber will provide detailed guidance on recognising warning signs that require immediate medical attention.

Pregnant or breastfeeding women should not use GLP-1 weight loss medications, and treatment should be discontinued at least two months before planned conception due to the long half-life of these compounds. Patients taking certain medications, including insulin or sulphonylureas, require dose adjustments to prevent hypoglycaemic episodes. Full contraindication screening occurs during your online consultation to ensure safe prescribing.

Monitoring and Follow-Up During Weight Loss Treatment

Successful weight management with GLP-1 medications requires ongoing monitoring and dose adjustments based on your response and tolerance. After starting treatment, most patients follow a structured dose escalation protocol, increasing the dose every 4 weeks until reaching the optimal maintenance level. Your prescriber will review your progress at each prescription renewal, assessing weight loss trajectory, side effect management, and any emerging concerns.

We recommend patients track their weight weekly and monitor for any unusual symptoms, particularly during the first three months of treatment. If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis, you should stop injections immediately and seek medical advice. Regular follow-up ensures your treatment remains safe, effective, and appropriately adjusted to your evolving clinical needs.

Starting Your Weight Loss Journey with Cured Pharmacy

Beginning prescription weight loss treatment at Cured Pharmacy is straightforward and completely remote. Our online consultation platform allows you to complete your medical assessment from home at any time, with prescriber reviews typically completed the same day. You'll receive email updates at each stage — consultation received, prescription approved, medication dispatched — so you're never uncertain about your order status.

All medications are dispensed from our GPhC-registered pharmacy and delivered in plain, discreet packaging with no external branding or content description. We use tracked courier services for all weight loss injection deliveries, ensuring your medication arrives safely and can be refrigerated promptly. Each package includes comprehensive patient information, injection technique guides, and sharps disposal information to support safe self-administration.

Our clinical team remains available throughout your treatment journey to answer questions, address concerns, or adjust your prescription as needed. Whether you're starting your first GLP-1 treatment or switching from another provider, Cured Pharmacy provides the clinical expertise, genuine medications, and transparent pricing you need to pursue your weight management goals with confidence.

Why Choose Cured Pharmacy for Weight Loss Prescriptions

Cured Pharmacy combines three critical elements often missing from online weight loss services: genuine UK-licensed medications, qualified prescriber oversight, and transparent upfront pricing. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees clinical governance, ensuring every prescription meets MHRA standards and GPhC guidelines for remote prescribing.

We never source medications from unregulated suppliers or grey-market channels. Every Mounjaro pen, Wegovy injection, and alternative treatment we dispense comes directly from UK-licensed wholesalers with full supply chain documentation. This guarantees proper storage conditions, authentic active ingredients, and valid expiry dates — critical factors for temperature-sensitive injectable medications that lose efficacy when mishandled.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment alongside dietary modifications and increased physical activity.